Dr Ruby Bunjun
Affiliations
- Fellow, Institute of Infectious Disease and Molecular Medicine
- Division of Medical Virology, Division of Pathology, University of Cape Town
- Honorary Research Fellow, Blizard Institute, Queen Mary University of London
Key Expertise
Co-Infection, HIV, Pathogenesis, SARS-CoV-2, T-and B-cell Immunology
Main Research Focus
Dr Bunjun's research focuses on understanding immunity to infectious diseases in Africa with a focus on understudied or vulnerable populations. Her current projects investigate pre-existing immunity to SARSCoV-2 in adolescents, and the immunomodulatory effects of azithromycin in advanced HIV. Dr Bunjun is a Carnegie Corporation DEAL and EDCTP2 Career Development alumnus, and currently holds a UKRI-UK/MRC African Research Leaders Fellowship.
Most Significant Paper Authored in 2025
Bunjun, R., Lurie, M., Dabee, S., Barnabas, S., Maseko, V., Jaumdally, S. Z., Gamieldien, H., Lewis, D. A., Jaspan, H. B., Gill, K., Bekker, L.-G., & Passmore, J.-A. S. (2025).
This study reveals insights into immunity against Chlamydia trachomatis, the most common bacterial STI, in the context of multiple exposures. In young women, recurrent/untreated infections were associated with cervical T cell activation, and a 2.4-fold lower peripheral CD4+ T cell response, compared to women with cleared or primary C. trachomatis infections. Furthermore, multifunctional Th1 cells were highest in women with cleared infections, and nearly absent in the untreated. Immune responses inversely correlated with genital tract inflammation, suggesting a role in limiting immunopathology. These findings highlight that both the magnitude and quality of the T cell response are required for protection.